Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

Affiliations

• ¹ Mayo Clinic Scottsdale, 13400 East Shea Boulevard, Scottsdale, AZ, 85259, USA. [email protected].
• ² Departments of Dermatology and Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX, 77030, USA.
• ³ Service de Dermatologie, Hôpital Saint-Louis, 1 av claude Vellefaux, 75010, Paris, France.
• ⁴ Studienzentrum Dermatologische Onkologie, Universitätsklinikum Tübingen, Liebermeisterstr. 25, 72074, Tübingen, Germany.
• ⁵ Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Würzburg, Josef-Schneider-Str. 2, 97080, Würzburg, Germany.
• ⁶ University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI, 48109, USA.
• ⁷ Department of Dermatology, University of Pennsylvania Medical Center, 3400 Civic Center Boulevard, Philadelphia, PA, 19104, USA.
• ⁸ Clinique de Dermatologie, Hôpital Claude Huriez, Inserm U1189, Lille, France.
• ⁹ Dermatology Department, St George Clinical School, University of New South Wales, Grey Street, Sydney, 2217, Australia.
• ¹⁰ The Angeles Clinic and Research Institute, 1818 Wilshire Boulevard, California, Los Angeles, USA.
• ¹¹ Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
• ¹² Genentech, Inc., 1 DNA Way, South San Francisco, California, 94080, USA.
• ¹³ Roche Products Limited, Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, Al7 1TW, UK.
• ¹⁴ Klinikum für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Essen, Hufelandstrabe 55, 45147, Essen, Germany.
• ¹⁵ Universitätsklinikum Schleswig-Holstein, Schittenhelmstr, 7, D-24 105, Kiel, Germany.